• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643668)   Today's Articles (13)   Subscriber (50599)
For: Osakada F, Sasai Y, Takahashi M. Control of neural differentiation from pluripotent stem cells. Inflamm Regen 2008. [DOI: 10.2492/inflammregen.28.166] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]  Open
Number Cited by Other Article(s)
1
Osakada F. Nuclear reprogramming to treat retinal degenerative diseases. Inflamm Regen 2011. [DOI: 10.2492/inflammregen.31.33] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]  Open
2
Induced pluripotent stem cells for retinal degenerative diseases: a new perspective on the challenges. J Genet 2009;88:417-24. [DOI: 10.1007/s12041-009-0063-5] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
3
Osakada F, Takahashi M. Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Targeting the Wnt Pathway and Transplantation Therapy as Strategies for Retinal Repair. J Pharmacol Sci 2009;109:168-73. [DOI: 10.1254/jphs.08r19fm] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA